TY - JOUR
T1 - Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis
AU - The British paediatric Rheumatology Study Group
AU - Zeggini, E.
AU - Thomson, W.
AU - Alansari, A.
AU - Ollier, W.
AU - Donn, R.
AU - Abinun, M.
AU - Becker, M.
AU - Bell, A.
AU - Craft, A.
AU - Crawley, E.
AU - David, J.
AU - Gardener-Medwin, J.
AU - Griffin, J.
AU - Hall, A.
AU - Hall, M.
AU - Herrick, A.
AU - Hollingworth, P.
AU - Holt, L.
AU - Jones, S.
AU - Pountain, G.
AU - Ryder, C.
AU - Southwood, T.
AU - Stewart, I.
AU - Woo, P.
AU - Wyatt, S.
AU - Venning, H.
PY - 2002
Y1 - 2002
N2 - Objectives. Juvenile idiopathic arthritis (JIA) is a complex polygenic disorder. The encouraging outcome of anti-tumour necrosis factor (TNF) treatment, as well as serological studies, has implicated TNF and its receptors (TNFRI and TNFRII, or TNFRSF1B) in the pathogenesis of JIA. The purpose of this study was to investigate the exon 6 TNFRII single nucleotide polymorphism (SNP) in a well-defined UK cohort of JIA patients, using case-control association analysis. Methods. A total of 435 patients, spanning seven JIA subgroups, and 261 healthy individuals were screened for the polymorphism using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results. No significant differences were observed between the SNP allelic or genotypic frequencies of patients and controls, or between JIA subgroups. Conclusions. This TNFRII exon 6 SNP does not seem to be associated with susceptibility to JIA.
AB - Objectives. Juvenile idiopathic arthritis (JIA) is a complex polygenic disorder. The encouraging outcome of anti-tumour necrosis factor (TNF) treatment, as well as serological studies, has implicated TNF and its receptors (TNFRI and TNFRII, or TNFRSF1B) in the pathogenesis of JIA. The purpose of this study was to investigate the exon 6 TNFRII single nucleotide polymorphism (SNP) in a well-defined UK cohort of JIA patients, using case-control association analysis. Methods. A total of 435 patients, spanning seven JIA subgroups, and 261 healthy individuals were screened for the polymorphism using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results. No significant differences were observed between the SNP allelic or genotypic frequencies of patients and controls, or between JIA subgroups. Conclusions. This TNFRII exon 6 SNP does not seem to be associated with susceptibility to JIA.
KW - Complex genetic disease
KW - Juvenile idiopathic arthritis
KW - Single nucleotide polymorphism
KW - Tumour necrosis factor receptor II
UR - http://www.scopus.com/inward/record.url?scp=0036100840&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036100840&partnerID=8YFLogxK
U2 - 10.1093/rheumatology/41.4.462
DO - 10.1093/rheumatology/41.4.462
M3 - Article
C2 - 11961180
AN - SCOPUS:0036100840
SN - 1462-0324
VL - 41
SP - 462
EP - 465
JO - Rheumatology
JF - Rheumatology
IS - 4
ER -